Shafina Siddiqui1, Shine Devarajan1, Soumya Basu2 and Jyotirmoi Aich1*
1School of Biotechnology and Bioinformatics, DY Patil Deemed to Be University, CBD Belapur, Maharashtra, India
2Cancer and Translational Research Laboratory, Dr. D.Y. Patil Biotechnology and Bioinformatics Institute, Dr. D. Y. Patil Vidyapeeth, Maharashtra, India
*Corresponding Author: Jyotirmoi Aich, School of Biotechnology and Bioinformatics, DY Patil Deemed to Be University, CBD Belapur, Maharashtra, India.
Received: September 07, 2021; Published: November 01, 2021
Science and technology has greatly advanced in the past few years, and is progressing at an unmatched rate. With the several advancements, it has brought a lot of ease to the overall drug discovery and development method. It is known that the de novo development of drug is an extremely time-consuming and expensive process. Therefore, in order to find its potential alternative, ‘Drug Repurposing’ has come into practice for many years. Drug Repurposing has been considered as a revolutionary breakthrough in accelerating the process of drug development process. It involves seeking new indications of drugs that already been approved by Food and Drug Administration, thereby substantial reduction of cost and time. Ever-increasing molecular, genomic and pharmacological data has further contributed in the success of drug repurposing approaches. This editorial outlines the different tools used in Drug Repurposing
Keywords: Drug Repurposing; In-silico Methods; Genomics; High-Throughput Sequencing Technologies; Literature Mining
Citation: Jyotirmoi Aich., et al. “Drug Repurposing: An Emerging Tool to Accelerate the Drug Development Process”. Acta Scientific Cancer Biology 5.12 (2021): 01-04.
Copyright: © 2021 Jyotirmoi Aich., et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.